Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“However, ximelagatran produces a three-fold elevation in alanine transaminase levels in 7.9% of patients treated for more than a month, the long-term significance of which is uncertain.”
Journal of thrombosis and haemostasis : JTH • 2005 | View Paper
“However, ximelagatran produces a three‐fold elevation in alanine transaminase levels in 7.9% of patients treated for more than a month, the long‐term significance of which is uncertain.”